{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T20:10:33Z","timestamp":1769112633126,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iLIVER"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.iliver.2022.11.003","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T04:39:14Z","timestamp":1669178354000},"page":"209-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Role of PIVKA-II in screening for malignancies at a hepatobiliary and pancreatic disease center: A large-scale real-world study"],"prefix":"10.1016","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4288-2481","authenticated-orcid":false,"given":"Chenghao","family":"Ge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingjie","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiyuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tengjiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.iliver.2022.11.003_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J Clin"},{"issue":"Suppl 1","key":"10.1016\/j.iliver.2022.11.003_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.31288","article-title":"Epidemiology of hepatocellular carcinoma","volume":"73","author":"McGlynn","year":"2021","journal-title":"Hepatol (Baltimore, Md)"},{"issue":"1","key":"10.1016\/j.iliver.2022.11.003_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Prim"},{"issue":"10127","key":"10.1016\/j.iliver.2022.11.003_bib4","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet (London, England)"},{"issue":"2","key":"10.1016\/j.iliver.2022.11.003_bib5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s12253-019-00585-5","article-title":"Current status and perspective biomarkers in AFP negative HCC: towards screening for and diagnosing hepatocellular carcinoma at an earlier stage","volume":"26","author":"Luo","year":"2020","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"10.1016\/j.iliver.2022.11.003_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3350\/cmh.2016.22.1.7","article-title":"A\u00a0concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016","volume":"22","author":"Yu","year":"2016","journal-title":"Clin Mol Hepatol"},{"issue":"3","key":"10.1016\/j.iliver.2022.11.003_bib7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000514174","article-title":"Management of hepatocellular carcinoma in Japan: JSH consensus statements and recommendations 2021 update","volume":"10","author":"Kudo","year":"2021","journal-title":"Liver Cancer"},{"issue":"23","key":"10.1016\/j.iliver.2022.11.003_bib8","first-page":"6493","article-title":"Isolation and characterization of a hepatoma-associated abnormal (des-gamma-carboxy)prothrombin","volume":"49","author":"Liebman","year":"1989","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.iliver.2022.11.003_bib9","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.hbpd.2018.09.009","article-title":"Protein induced by vitamin K absence or antagonist-II versus alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: a systematic review with meta-analysis","volume":"17","author":"Xing","year":"2018","journal-title":"Hepatobiliary Pancreat Dis Int : HBPD INT."},{"issue":"4","key":"10.1016\/j.iliver.2022.11.003_bib10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","article-title":"Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update","volume":"11","author":"Omata","year":"2017","journal-title":"Hepatol Int"},{"issue":"2","key":"10.1016\/j.iliver.2022.11.003_bib11","doi-asserted-by":"crossref","DOI":"10.11613\/BM.2019.020707","article-title":"Protein Induced by Vitamin K Absence II (PIVKA-II) as a potential serological biomarker in pancreatic cancer: a pilot study","volume":"29","author":"Tartaglione","year":"2019","journal-title":"Biochem Med"},{"issue":"5","key":"10.1016\/j.iliver.2022.11.003_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251656","article-title":"PIVKA-II: a biomarker for diagnosing and monitoring patients with pancreatic adenocarcinoma","volume":"16","author":"Tartaglione","year":"2021","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.iliver.2022.11.003_bib13","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.dld.2018.08.019","article-title":"Novel biomarkers in hepatocellular carcinoma","volume":"50","author":"De Stefano","year":"2018","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.iliver.2022.11.003_bib14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clinbiochem.2020.06.014","article-title":"Real-world big-data studies in laboratory medicine: current status, application, and future considerations","volume":"84","author":"Ma","year":"2020","journal-title":"Clin Biochem"},{"issue":"11","key":"10.1016\/j.iliver.2022.11.003_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24013","article-title":"The clinical application of PIVKA-II in hepatocellular carcinoma and chronic liver diseases: a multi-center study in China","volume":"35","author":"Ji","year":"2021","journal-title":"J\u00a0Clin Lab Anal"},{"issue":"9","key":"10.1016\/j.iliver.2022.11.003_bib16","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1080\/17474124.2021.1900731","article-title":"Do combined assays of serum AFP, AFP-L3, DCP, GP73, and DKK-1 efficiently improve the clinical values of biomarkers in decision-making for hepatocellular carcinoma? A meta-analysis","volume":"15","author":"Fang","year":"2021","journal-title":"Expet Rev Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.iliver.2022.11.003_bib17","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/jgh.12166","article-title":"Novel des-\u03b3-carboxy prothrombin in serum for the diagnosis of hepatocellular carcinoma","volume":"28","author":"Tanaka","year":"2013","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.iliver.2022.11.003_bib18","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1643::AID-CNCR8>3.0.CO;2-B","article-title":"The usefulness of determining des-gamma-carboxy prothrombin by sensitive enzyme immunoassay in the early diagnosis of patients with hepatocellular carcinoma","volume":"82","author":"Mita","year":"1998","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.iliver.2022.11.003_bib19","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/hep.1840060410","article-title":"Serum mitochondrial aspartate aminotransferase as a marker of chronic alcoholism: diagnostic value and interpretation in a liver unit","volume":"6","author":"Nalpas","year":"1986","journal-title":"Hepatol (Baltimore, Md)"},{"key":"10.1016\/j.iliver.2022.11.003_bib20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.canlet.2019.11.029","article-title":"Mitochondrial metabolic reprogramming: an important player in liver cancer progression","volume":"470","author":"Jin","year":"2020","journal-title":"Cancer Lett"},{"issue":"3","key":"10.1016\/j.iliver.2022.11.003_bib21","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317695944","article-title":"Stratified aspartate aminotransferase-to-platelet ratio index accurately predicts survival in hepatocellular carcinoma patients undergoing curative liver resection","volume":"39","author":"Yang","year":"2017","journal-title":"Tumour Biol: J Int Soc Oncodevelopmental Bio Med"},{"issue":"9","key":"10.1016\/j.iliver.2022.11.003_bib22","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/hep4.1570","article-title":"Elevated aspartate aminotransferase to alanine aminotransferase ratio predicts poor outcome in hepatocellular carcinoma","volume":"4","author":"von Felden","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.iliver.2022.11.003_bib23","doi-asserted-by":"crossref","first-page":"15447","DOI":"10.1007\/s13277-016-5443-x","article-title":"Clinical application of protein induced by vitamin K antagonist-II as a biomarker in hepatocellular carcinoma","volume":"37","author":"Xing","year":"2016","journal-title":"Tumour Biol: J Int Soc Oncodevelopmental Bio Med"},{"issue":"12","key":"10.1016\/j.iliver.2022.11.003_bib24","first-page":"5415","article-title":"Effect of menatetrenone, a vitamin k2 analog, on recurrence of hepatocellular carcinoma after surgical resection: a prospective randomized controlled trial","volume":"32","author":"Ishizuka","year":"2012","journal-title":"Anticancer Res"},{"issue":"10","key":"10.1016\/j.iliver.2022.11.003_bib25","first-page":"552","article-title":"Serum des-gamma-carboxyprothrombin in patients with pancreatic head adenocarcinoma","volume":"112","author":"Kemik","year":"2011","journal-title":"Bratisl Lek Listy"},{"issue":"1","key":"10.1016\/j.iliver.2022.11.003_bib26","first-page":"17","article-title":"Pathophysiological consequences of obstructive jaundice and perioperative management. Hepatobiliary & pancreatic diseases international","volume":"17","author":"Pavlidis","year":"2018","journal-title":"HBPD INT"}],"container-title":["iLIVER"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772947822000809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772947822000809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:31:29Z","timestamp":1762648289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772947822000809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2772947822000809"],"URL":"https:\/\/doi.org\/10.1016\/j.iliver.2022.11.003","relation":{},"ISSN":["2772-9478"],"issn-type":[{"value":"2772-9478","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of PIVKA-II in screening for malignancies at a hepatobiliary and pancreatic disease center: A large-scale real-world study","name":"articletitle","label":"Article Title"},{"value":"iLIVER","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iliver.2022.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd on behalf of Tsinghua University Press.","name":"copyright","label":"Copyright"}]}}